ANI Pharmaceuticals, Inc. (BST:BSFA)

ANI Pharmaceuticals Revenue

ANI Pharmaceuticals had revenue of $227.81M USD in the quarter ending September 30, 2025, with 53.58% growth. This brings the company's revenue in the last twelve months to $826.88M, up 48.87% year-over-year. In the year 2024, ANI Pharmaceuticals had annual revenue of $614.38M with 26.20% growth.

• Revenue (ttm): $826.88M
• Revenue Growth: +48.87%
• P/S Ratio: 2.08
• Revenue / Employee: $921.83K
• Employees: 897
• Market Cap: 1.47B EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	614.38M	127.56M	26.20%
Dec 31, 2023	486.82M	170.43M	53.87%
Dec 31, 2022	316.39M	100.25M	46.38%
Dec 31, 2021	216.14M	7.66M	3.67%
Dec 31, 2020	208.48M	1.93M	0.93%
Dec 31, 2019	206.55M	4.97M	2.47%
Dec 31, 2018	201.58M	24.73M	13.99%
Dec 31, 2017	176.84M	48.22M	37.49%
Dec 31, 2016	128.62M	52.30M	68.53%
Dec 31, 2015	76.32M	20.35M	36.36%
Dec 31, 2014	55.97M	25.89M	86.06%
Dec 31, 2013	30.08M	9.71M	47.67%
Dec 31, 2012	20.37M	19.94M	4,581.27%
Dec 31, 2011	435.16K	-2.04M	-82.41%
Dec 31, 2010	2.47M	1.22M	96.67%
Dec 31, 2009	1.26M	-2.52M	-66.73%
Dec 31, 2008	3.78M	3.29M	666.82%
Dec 31, 2007	493.05K	-13.95M	-96.59%
Dec 31, 2006	14.44M	14.18M	5,488.76%
Dec 31, 2005	258.35K	-	-